Gensco’s Astero hydrogel alleviates diabetic foot ulcers
As seen in Chain Drug Review’s Diabetes Care Report.
Approximately 15% of people with diabetes suffer from foot ulcers, and treating them properly can be challenging for the patient. However, failure to do so, with resulting infection, carries the danger of eventual amputation.
A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds
By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot.
Wound pain has numerous, often interlinked, causes that may relate to the initial injury, the inflammatory response or infection. Pain may also result from interventions, such as dressing removal, cleansing, debridement, compression therapy, or topical treatments. Pain as a result of trauma, particularly during the dressing change procedure, has been described by patients as the worst part of dealing with a wound.1
MDose v Tube Study
MDose™ Technology Background It has been shown that convenience, ease of dispensing and favorable tolerability are key characteristics that may increase patient compliance with topical dermatologic therapy.[1],[2],[3] Additionally, the quantity of drug utilized with...
Medicare (CGDP) Gap Announcement
Gensco Pharma Announces Additions to 2017 CGDP on CMS Gensco products will be available to MEDICARE patients in 2017Supply Partners
Gensco Pharma is a FDA licensed pharmaceutical manufacturer focusing on the research, development and marketing of transdermal prescription products. As an innovator of pharmaceutical products, Gensco Pharma currently delivers non-narcotic transdermal analgesic gels...
ColciGel®: A Superior Alternative for Acute Gout Flares
By Gary E. Myerson, MD, Marc Alan Brenner, DPM, Robert L. Wilbur, Pharm.D., CPh | Director, Medical Affairs
A new agent, ColciGel®, has recently emerged for the treatment of acute flares of gout. ColciGel is a transdermal gel preparation of Colchicinum (colchicine in its homeopathic state) that is applied topically. ColciGel contains Colchicinum 4X in a proprietary Organogel that is applied directly to the site of acute flares.
Got Pain?
Transdermal Pharmaceuticals Clinically Proven APPA | September 2016 Chain Drug Review | July 2016 Chain Drugstore Daily | April 2016
Pharmacoeconomics of ColciGel for the Treatment of Acute Gout Flares
By Gary E. Myerson, MD
Oral Colchicine was effective in only 38% of patients treated for acute flares.1 It is associated with poor tolerability due to a high-rate of gastrointestinal effects; typically nausea, vomiting, abdominal cramps and diarrhea. Less common but more significant is a strong potential for drug-drug interactions with oral colchicine as it is metabolized and transported by cytochrome P450-3A4 and P-glycoprotein, two systems used by many other drugs.2 Fatalities have occurred from these drug-drug interactions with colchicine.3 4
Fast Relief for Painful Wounds
Astero™ is a FDA approved hydrogel plus topical anesthetic (Lidocaine 4%) indicated for painful wounds such as post-surgical incisions, ulcers, cuts and abrasions. Chain Drug Review | November 2016 Chain Drug Review | September 2016 Podiatry Management | August 2016...LOOKING TO THE FUTURE
A single dose topical colchinium for acute gout flares.